Elizabeth Kiracofe, MD, FAAD

Focusing on pregnant patients with atopic dermatitis who are treatment naïve, Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, discuss best practices for informing patients on the available treatment options for this condition.

Jenny Murase, MD, provides a brief overview of the Fc receptor and the role of transcription binding in atopic dermatitis.

Dermatologists provide clinical insights on how they discuss atopic dermatitis treatment options, considerations, and safety concerns with patients who are pregnant or of childbearing age.

Jenny Murase, MD, describes how rising estrogen levels cause a shift in immune response from Th1 to Th2, causing potential atopic dermatitis exacerbations for patients who are pregnant.

Experts on atopic dermatitis discuss the importance of open dialogue with patients who are pregnant or of childbearing potential regarding the safety concerns associated with treatments for this condition.

Dr. Elizabeth Kiracofe, MD, FAAD, and Dr. Jenny Murase, MD, introduce a discussion on the undertreatment of patients with atopic dermatitis, particularly focusing on pregnant individuals and those of childbearing age.

Dr. Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.

Elizabeth Kiracofe, MD, FAAD presents a case of a 42-year-old woman with facial vitiligo, emphasizing the need for personalized treatment plans. She shares insights on patient follow-up, monitoring practices, and physician preferences in treatment modalities based on the vehicle.